Nasty or Nice? A Perspective on the Use of Health Technology Assessment in the United Kingdom

被引：27

作者：

Drummond, Michael ^{[1
]}

Sorenson, Corinna ^{[2
]}

机构：

[1] Univ York, Ctr Hlth Econ, York YO1O 5DD, N Yorkshire, England

[2] London Sch Econ, LSE Hlth & Social Care, London WC2A 2AE, England

来源：

VALUE IN HEALTH | 2009年 / 12卷

关键词：

health technology assessment; HTA; National Institute for Clinical Excellence; NICE; United Kingdom; CLINICAL EXCELLENCE; NATIONAL INSTITUTE; DECISION-MAKING; GUIDANCE; NHS; OFT;

D O I：

10.1111/j.1524-4733.2009.00552.x

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

[No abstract available]

引用

页码：S8 / S13

页数：6

共 29 条

[1] [Anonymous], 1996, Cost-effectiveness in health and medicine
[2] [Anonymous], SOC VAL JUDG
[3] [Anonymous], 2006, GUID EC EV HLTH TECH, V3rd
[4] [Anonymous], 2007, PHARM PRIC REG SCHEM
[5] [Anonymous], 2008, Guide to the methods of technology appraisal
[6] *AUD COMM, 2005, MAN FIN IMPL NICE GU
[7] BARBIERI M, 2007, HLTH EC STUD GROUP M
[8] Who Does the Numbers? The Role of Third-Party Technology Assessment to Inform Health Systems' Decision-Making about the Funding of Health Technologies
Barbieri, Marco
Hawkins, Neil
Sculpher, Mark
[J]. VALUE IN HEALTH, 2009, 12 (02) : 193 - 201
[9] Information created to evade reality (ICER) - Things we should not look to for answers
Birch, Stephen
Gafni, Amiram
[J]. PHARMACOECONOMICS, 2006, 24 (11) : 1121 - 1131
[10] BUXTON M, 1985, COSTS BENEFITS HEART

← 1 2 3 →